- 全部删除
- 您的购物车当前为空
GRC-17536 is an orally available, potent, and selective transient receptor potential anchor protein 1 (TRPA1) inhibitor that has been shown to be highly effective in the treatment of inflammation and neuropathic pain in animal models. The selectivity of GRC-17536 is more than 1000 times higher than that of other TRPs, numerous GPCRs, enzymes, and other ion channels.
GRC-17536 is an orally available, potent, and selective transient receptor potential anchor protein 1 (TRPA1) inhibitor that has been shown to be highly effective in the treatment of inflammation and neuropathic pain in animal models. The selectivity of GRC-17536 is more than 1000 times higher than that of other TRPs, numerous GPCRs, enzymes, and other ion channels.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 10,600 | 期货 |
产品描述 | GRC-17536 is an orally available, potent, and selective transient receptor potential anchor protein 1 (TRPA1) inhibitor that has been shown to be highly effective in the treatment of inflammation and neuropathic pain in animal models. The selectivity of GRC-17536 is more than 1000 times higher than that of other TRPs, numerous GPCRs, enzymes, and other ion channels. |
别名 | GRC17536, GRC 17536 |
分子量 | 554.55 |
分子式 | C20H12F5KN4O3S2 |
CAS No. | 1649479-05-9 |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容